<i>IFNL4</i> Genotype Frequencies in Asian Populations Support Shorter Duration Therapy with Sofosbuvir-Based Hepatitis C Virus Regimens to Increase the Number Cured-Reference-Cited by-同舟云学术

IFNL4 Genotype Frequencies in Asian Populations Support Shorter Duration Therapy with Sofosbuvir-Based Hepatitis C Virus Regimens to Increase the Number Cured

Published:2023-09-01 Issue:9 Volume:43 Page:435-438
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

O'Brien Thomas R.¹^ORCID,Lee Mei-Hsuan²,Wilson Eleanor³,Kottilil Shyam³

Affiliation:

1. Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

2. Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.

3. Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jir.2023.0022

Reference20 articles.

1. Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus

2. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

3. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

4. An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms

5. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C;Journal of Infection;2024-11

2. The Interferon-Lambda Family Celebrates 20 Years of Scientific Discovery;Journal of Interferon & Cytokine Research;2023-09-01